OrfoNeuro ApS: Financial statements 2020
CVR: 37768901
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -155,041 and a net result of DKK -152,909 compared with DKK -140,299 the year before. Equity in the 2020 report amounted to DKK -416,050.
- Gross Profit
- DKK -155,041
- Profit/Loss
- DKK -152,909
- Equity
- DKK -416,050
- Total Assets
- DKK 51,706
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -155 t. | -153 t. | -416 t. | 0 |
| 2019 | - | -146 t. | -140 t. | -263 t. | 0 |
| 2018 | - | -204 t. | -166 t. | -123 t. | 0 |
| 2017 | - | -7 t. | -7 t. | 43 t. | 0 |
Official annual report
How creditworthy is OrfoNeuro ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
OrfoNeuro ApS has published its annual report for 2019. Gross profit came to DKK -145,897, and the net result was DKK -140,299.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.